Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Markers of Treatment Outcomes in Social Anxiety
NCT05683223Recruiting
- Start
- May 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sertraline in Social Anxiety Disorder (SAD) (3 arms). Primary endpoints: Clinical Global Impression-Improvement Scale at 25 weeks and Liebowitz Social Anxiety Scale at 25 weeks. Started May 2023; status: recruiting.
02
Drugs
sertraline
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05683223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683223.